Mesoblast Limited (MSB.AX) - Stock Prices, Stock Peers & Analysis

Home
MSB.AX

Company Name	Mesoblast Limited
Symbol	MSB.AX
Currency	AUD
Price	0.92
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	1,049,938,129
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.255 - 1.33
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)
Website	https://www.mesoblast.com

An error occurred while fetching data.

About Mesoblast Limited

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized